Lawrence Saperstein, MD

home / authors / lawrence-saperstein-md

Articles

The Future of Prostate Cancer Imaging

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 25th 2022

Prostate cancer experts highlight some closing thoughts and exciting research in progress on prostate cancer imaging.

Prostate Cancer Imaging: the VISION Trial

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 25th 2022

Neal Shore, MD, FACS, reviews the VISION clinical trial in prostate cancer imaging.

Patient Profile 7: Gleason 7 Prostate Cancer

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 25th 2022

A look at the patient profile of a 62-year-old man presenting with reduced urinary flow and hematuria.

Patient Profile 6: Robotic Radical Prostatectomy for Adenocarcinoma

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 18th 2022

Dr Steven Finkelstein explains a clinical example of a 65-year-old patient with a history of robotic radical prostatectomy for Gleason 9 adenocarcinoma.

Patient Profile 5: IMRT for Adenocarcinoma

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 18th 2022

Dr Lawrence Saperstein describes the patient profile of a 78-year-old man with a history of intensity-modulated radiation therapy for adenocarcinoma.

Prostate Cancer Imaging: the CONDOR Trial

Neal Shore, MD, FACS;Steven Finkelstein, MD, DABR, FACRO;Michael Gorin, MD;Lawrence Saperstein, MD

May 11th 2022

Key opinion leaders review the CONDOR clinical trial studying PSMA PET scans for prostate cancer imaging.

Patient Profile 4: Recurrent Prostate Cancer

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 11th 2022

Michael Gorin, MD, presents a clinical example of a 60-year-old patient with recurrent prostate cancer.

Bone Scans for Prostate Cancer Imaging

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 5th 2022

A panel of experts review whether bone scans still have a place in prostate cancer imaging.

Patient Profile 3: High-Risk Prostate Cancer

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 5th 2022

Steven Finkelstein, MD, DABR, FACRO, presents a high-risk prostate cancer patient profile for a 74-year-old man with a history of chronic prostatitis.

Patient Profile 2: High-Risk Prostate Cancer

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 29th 2022

Lawrence Saperstein, MD, reviews the patient profile of a 65-year-old man with high-risk prostate cancer.

The Role for PSMA PET Imaging in Prostate Cancer Monitoring

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 29th 2022

A look at how PSMA PET imaging fits into the monitoring of a patient with prostate cancer.

Discussing Treatments with Patients Based on Prostate Cancer Imaging

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 20th 2022

A radiation oncologist explains how to discuss the interpretation of prostate cancer imaging with patients in deciding on a treatment plan.